102 related articles for article (PubMed ID: 16125761)
1. The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer.
Engelstad LP; Stewart S; Otero-Sabogal R; Leung MS; Davis PI; Pasick RJ
Prev Med; 2005; 41(3-4):741-8. PubMed ID: 16125761
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a call/recall system in improving compliance with cervical cancer screening: a randomized controlled trial.
Buehler SK; Parsons WL
CMAJ; 1997 Sep; 157(5):521-6. PubMed ID: 9294390
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening.
Yabroff KR; Kerner JF; Mandelblatt JS
Prev Med; 2000 Oct; 31(4):429-39. PubMed ID: 11006069
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
5. Encouraging underscreened women to have cervical cancer screening: the effectiveness of a computer strategy.
Campbell E; Peterkin D; Abbott R; Rogers J
Prev Med; 1997; 26(6):801-7. PubMed ID: 9388791
[TBL] [Abstract][Full Text] [Related]
6. Adherence to cervical and breast cancer programs is crucial to improving screening performance.
Mauad EC; Nicolau SM; Moreira LF; Haikel RL; Longatto-Filho A; Baracat EC
Rural Remote Health; 2009; 9(3):1241. PubMed ID: 19778158
[TBL] [Abstract][Full Text] [Related]
7. Papanicolaou testing among Vietnamese Americans: results of a multifaceted intervention.
Nguyen TT; McPhee SJ; Gildengorin G; Nguyen T; Wong C; Lai KQ; Lam H; Mock J; Luong TN; Bui-Tong N; Ha-Iaconis T
Am J Prev Med; 2006 Jul; 31(1):1-9. PubMed ID: 16777536
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services.
Lynch FL; Whitlock EP; Valanis BG; Smith SK
Prev Med; 2004 Apr; 38(4):403-11. PubMed ID: 15020173
[TBL] [Abstract][Full Text] [Related]
9. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.
Howell LP; Gurusinghe S; Tabnak F
Diagn Cytopathol; 2009 Feb; 37(2):103-10. PubMed ID: 19021201
[TBL] [Abstract][Full Text] [Related]
10. The costs of an outreach intervention for low-income women with abnormal Pap smears.
Wagner TH; Engelstad LP; McPhee SJ; Pasick RJ
Prev Chronic Dis; 2007 Jan; 4(1):A11. PubMed ID: 17173719
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a minimal self-help smoking cessation intervention following cervical cancer screening.
McBride CM; Scholes D; Grothaus LC; Curry SJ; Ludman E; Albright J
Prev Med; 1999 Aug; 29(2):133-8. PubMed ID: 10446040
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a community outreach service with opportunity screening for cervical cancer using Pap smears.
Chang HC; Hsiung HY; Chen SI; Yen AM; Chen TH
J Public Health (Oxf); 2007 Jun; 29(2):165-72. PubMed ID: 17389674
[TBL] [Abstract][Full Text] [Related]
14. The safety net: a cost-effective approach to improving breast and cervical cancer screening.
Vogt TM; Glass A; Glasgow RE; La Chance PA; Lichtenstein E
J Womens Health (Larchmt); 2003 Oct; 12(8):789-98. PubMed ID: 14588129
[TBL] [Abstract][Full Text] [Related]
15. "Health is strength": a community health education program to improve breast and cervical cancer screening among Korean American Women in Alameda County, California.
Moskowitz JM; Kazinets G; Wong JM; Tager IB
Cancer Detect Prev; 2007; 31(2):173-83. PubMed ID: 17418978
[TBL] [Abstract][Full Text] [Related]
16. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Pap screening among Mexican-American women: impediments to receiving and reporting follow-up care.
Hunt LM; de Voogd KB; Akana LL; Browner CH
Oncol Nurs Forum; 1998; 25(10):1743-9. PubMed ID: 9826840
[TBL] [Abstract][Full Text] [Related]
18. Understanding barriers for adherence to follow-up care for abnormal pap tests.
Eggleston KS; Coker AL; Das IP; Cordray ST; Luchok KJ
J Womens Health (Larchmt); 2007 Apr; 16(3):311-30. PubMed ID: 17439377
[TBL] [Abstract][Full Text] [Related]
19. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
20. What predicts adherence to follow-up recommendations for abnormal Pap tests among older women?
Coker AL; Eggleston KS; Meyer TE; Luchok K; Das IP
Gynecol Oncol; 2007 Apr; 105(1):74-80. PubMed ID: 17157363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
